MEET US 2025
Farmaforum: Madrid, ES | 17–18 Sep 2025
|
Bioproduction Congress (BIOPC): Lyon, FR | 22 – 23 Sep 2025
|
KoNECT-MOHW-MFDS International Conference: Seoul, KR | 22 – 24 Sep 2025
|
Festival of Biologics: Basel, CH | 30 Sep – 02 Oct 2025
|
BIOSPAIN: Barcelona, ES | 07-09 Oct 2025
|
ESGCT Congress: Sevilla, ES | 07-10 Oct 2025
|
BIOPLUS INTERPHEX KOREA: Seoul, KR | 15-17 Oct 2025
|
OTS Anual Meeting: Budapest, HU | 19-22 Oct 2025
|
CPHI 2025: Frankfurt, DE | 28-30 Oct 2025
|
I4ID MabDesign: Lyon, FR | 13-14 Nov 2025
|
European Bioanalysis Forum (EBF): Barcelona, ES | 18-20 Nov 2025
|
PharmaLab Congress: Düsseldorf, DE | 24-26 Nov 2025
|
BioFIT: Strasbourg, FR | 02-03 Dec 2025
logo-dark

Dr. Carles Celma

About Carles Celma

This author has not yet filled in any details.
So far Carles Celma has created 29 blog entries.

Denosumab Biosimilars: Accelerating Drug Development for RANKL Inhibitors

Denosumab represents one of the leading biologics applied today [...]

By |2025-01-27T10:00:27+01:0023. January 2025|Bioanalysis, Service|Comments Off on Denosumab Biosimilars: Accelerating Drug Development for RANKL Inhibitors

ICH M10 Comparison with EMA and FDA Past Guidelines on Bioanalytical Method Validation

Although the ICH has published recommendations for the validation of [...]

By |2024-09-04T14:20:34+02:004. September 2024|Bioanalysis|Comments Off on ICH M10 Comparison with EMA and FDA Past Guidelines on Bioanalytical Method Validation
Go to Top